Daily vitamin C shows survival promise in early blood disorders
In short
- The trial found patients taking daily vitamin C had fewer adverse events.
- Patients showed a promising survival advantage, according to the report.
- The findings come from a trial and still need further confirmation.
Why the Good News Desk likes this one
The trial looked at people with precancerous blood disorders and early-stage blood cancers. Those who took the supplement had fewer adverse events and a promising survival advantage. It is an early result, so it shows a direction worth testing rather than a proven treatment.
Advertisement
From ScienceDaily
A surprising clinical trial suggests that taking vitamin C daily could improve survival in people with precancerous blood disorders and early-stage blood cancers. Patients receiving the supplement had fewer adverse events and showed a promising survival advantage, raising hopes that a common vitamin could help protect against leukemia-related complications.
Ask this story
More like this
Advertisement